ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
22.539,98
1,71%
S&P 500
5.633,07
0,38%
Dow Jones
41.989,96
-0,03%
Euro vs US Dollar
1,07921
-0,03%
Bitcoin
84.319,70
-1,00%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Eledon Pharmaceuticals Inc (ELDN)

  7. Eledon Pharmaceuticals Inc (ELDN) News

ELDN

Eledon Pharmaceuticals (ELDN)

Eledon Pharmaceuticals Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ELDN
DatumZeitQuelleÜberschriftSymbolFirma
20/03/202522h00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ELDNEledon Pharmaceuticals Inc
20/03/202521h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELDNEledon Pharmaceuticals Inc
20/03/202521h01GlobeNewswire Inc.Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Operating and Financial ResultsNASDAQ:ELDNEledon Pharmaceuticals Inc
04/03/202522h05GlobeNewswire Inc.Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare ConferenceNASDAQ:ELDNEledon Pharmaceuticals Inc
14/02/202523h34Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ELDNEledon Pharmaceuticals Inc
14/02/202517h22Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ELDNEledon Pharmaceuticals Inc
07/02/202516h00GlobeNewswire Inc.Eledon Pharmaceuticals Announces Use of Tegoprubart as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a HumanNASDAQ:ELDNEledon Pharmaceuticals Inc
29/01/202522h05GlobeNewswire Inc.Eledon Pharmaceuticals to Participate in Guggenheim Securities SMID Cap Biotech ConferenceNASDAQ:ELDNEledon Pharmaceuticals Inc
13/01/202523h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELDNEledon Pharmaceuticals Inc
13/01/202523h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELDNEledon Pharmaceuticals Inc
13/01/202523h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELDNEledon Pharmaceuticals Inc
13/01/202523h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELDNEledon Pharmaceuticals Inc
13/01/202523h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELDNEledon Pharmaceuticals Inc
13/01/202523h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELDNEledon Pharmaceuticals Inc
13/01/202523h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELDNEledon Pharmaceuticals Inc
13/01/202523h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELDNEledon Pharmaceuticals Inc
13/01/202523h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELDNEledon Pharmaceuticals Inc
13/01/202513h00GlobeNewswire Inc.Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 OutlookNASDAQ:ELDNEledon Pharmaceuticals Inc
20/12/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELDNEledon Pharmaceuticals Inc
22/11/202423h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELDNEledon Pharmaceuticals Inc
22/11/202423h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELDNEledon Pharmaceuticals Inc
14/11/202422h51Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ELDNEledon Pharmaceuticals Inc
12/11/202423h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ELDNEledon Pharmaceuticals Inc
12/11/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELDNEledon Pharmaceuticals Inc
12/11/202422h01GlobeNewswire Inc.Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial ResultsNASDAQ:ELDNEledon Pharmaceuticals Inc
06/11/202422h05GlobeNewswire Inc.Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation ConferenceNASDAQ:ELDNEledon Pharmaceuticals Inc
05/11/202417h44Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:ELDNEledon Pharmaceuticals Inc
30/10/202411h36Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ELDNEledon Pharmaceuticals Inc
30/10/202411h24Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ELDNEledon Pharmaceuticals Inc
30/10/202402h27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELDNEledon Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ELDN

Kürzlich von Ihnen besucht

COIN
HBTUSD
Hubii Network
LSE
JCPN
Jhtab Japn Eqt
COIN
SFTYUST
Stella Fantasy Token
LSE
0QA2
Pcc Exol
BIT
IFFF
Exchange Trading Funds
NYSE
PFD
Flaherty & Crumrine Pref...
COIN
YBANUSD
BananoDOS
BOV
CABI3
Cabinda Participacoes ON
LSE
HMWS
Hsbc Msci Wd Ac
BITMOT
808942
Eib Tf 8% Ge27 Mxn
BIT
XBLC
iBoxx EUR LIQUID CORPORA...
BIBX
NEOETH
NEO
EU
MIVU
Amundi Msci Usa Minimum ...
TSXV
NBM
NEO Battery Materials
BIT
XSPX
S&P 500 ETF Class 1C sha...
BOV
SOMA3
Grupo De Moda Soma ON
Delayed Upgrade Clock
ADVFN Logo
Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten